IL129276A - Anticonvulsant derivatives useful in treating neuropathic pain - Google Patents

Anticonvulsant derivatives useful in treating neuropathic pain

Info

Publication number
IL129276A
IL129276A IL12927697A IL12927697A IL129276A IL 129276 A IL129276 A IL 129276A IL 12927697 A IL12927697 A IL 12927697A IL 12927697 A IL12927697 A IL 12927697A IL 129276 A IL129276 A IL 129276A
Authority
IL
Israel
Prior art keywords
neuropathic pain
derivatives useful
treating neuropathic
anticonvulsant derivatives
anticonvulsant
Prior art date
Application number
IL12927697A
Other languages
English (en)
Other versions
IL129276A0 (en
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL129276A0 publication Critical patent/IL129276A0/xx
Publication of IL129276A publication Critical patent/IL129276A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12927697A 1996-10-08 1997-07-16 Anticonvulsant derivatives useful in treating neuropathic pain IL129276A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2768796P 1996-10-08 1996-10-08
PCT/US1997/012350 WO1998015270A1 (en) 1996-10-08 1997-07-16 Anticonvulsant derivatives useful in treating neuropathic pain

Publications (2)

Publication Number Publication Date
IL129276A0 IL129276A0 (en) 2000-02-17
IL129276A true IL129276A (en) 2003-04-10

Family

ID=21839205

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12927697A IL129276A (en) 1996-10-08 1997-07-16 Anticonvulsant derivatives useful in treating neuropathic pain

Country Status (23)

Country Link
EP (1) EP0932400B1 (hu)
JP (1) JP4097294B2 (hu)
KR (1) KR100496934B1 (hu)
CN (1) CN1105559C (hu)
AP (1) AP1513A (hu)
AT (1) ATE226071T1 (hu)
AU (1) AU725570B2 (hu)
BR (1) BR9712503A (hu)
CA (1) CA2267945C (hu)
CZ (1) CZ296525B6 (hu)
DE (1) DE69716453T2 (hu)
DK (1) DK0932400T3 (hu)
ES (1) ES2187795T3 (hu)
HU (1) HU225031B1 (hu)
IL (1) IL129276A (hu)
NO (1) NO321390B1 (hu)
NZ (1) NZ334981A (hu)
PT (1) PT932400E (hu)
RU (1) RU2175868C2 (hu)
SI (1) SI0932400T1 (hu)
SK (1) SK284271B6 (hu)
UA (1) UA48256C2 (hu)
WO (1) WO1998015270A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU771388B2 (en) * 1999-01-19 2004-03-18 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating cluster headaches
AR022321A1 (es) * 1999-01-21 2002-09-04 Ortho Mcneil Pharm Inc Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
EP1345602B1 (en) * 2000-11-30 2010-07-21 Novodermix International Limited Wound healing
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
JP5912269B2 (ja) 2011-03-11 2016-04-27 ローランド株式会社 電子楽器
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine

Also Published As

Publication number Publication date
ES2187795T3 (es) 2003-06-16
NO321390B1 (no) 2006-05-08
JP4097294B2 (ja) 2008-06-11
DE69716453T2 (de) 2003-02-27
KR100496934B1 (ko) 2005-06-23
EP0932400B1 (en) 2002-10-16
HUP9904294A3 (en) 2001-08-28
JP2001501643A (ja) 2001-02-06
DK0932400T3 (da) 2003-02-10
PT932400E (pt) 2003-03-31
KR20000048871A (ko) 2000-07-25
UA48256C2 (uk) 2002-08-15
AP1513A (en) 2005-12-12
CN1232393A (zh) 1999-10-20
BR9712503A (pt) 1999-10-19
NZ334981A (en) 2000-08-25
WO1998015270A1 (en) 1998-04-16
AP9901508A0 (en) 1999-06-30
HUP9904294A2 (hu) 2001-04-28
ATE226071T1 (de) 2002-11-15
CZ115799A3 (cs) 1999-09-15
RU2175868C2 (ru) 2001-11-20
NO991621D0 (no) 1999-04-06
CA2267945C (en) 2005-05-17
EP0932400A1 (en) 1999-08-04
SI0932400T1 (en) 2002-12-31
SK45499A3 (en) 2000-08-14
HU225031B1 (en) 2006-05-29
DE69716453D1 (de) 2002-11-21
NO991621L (no) 1999-05-25
CN1105559C (zh) 2003-04-16
CA2267945A1 (en) 1998-04-16
IL129276A0 (en) 2000-02-17
CZ296525B6 (cs) 2006-04-12
AU725570B2 (en) 2000-10-12
AU3602297A (en) 1998-05-05
SK284271B6 (sk) 2004-12-01

Similar Documents

Publication Publication Date Title
ZA975772B (en) Anticonvulsant derivatives useful in treating obesity
PL329211A1 (en) Pain relieving method
AP9801427A0 (en) Anticonvulsant derivatives useful in treating manic depressive bipolar disorder
AP9801428A0 (en) Anticonvulsant derivatives useful in treating amyothrophic lateral sclerosis (als)
GB9609641D0 (en) Compounds useful in therapy
GB9605175D0 (en) Improvements in or relating to securing apparatus
HU9702042D0 (en) Atherosclerosis treatment
GB9519033D0 (en) Treatment
ZA975769B (en) Anticonvulsant derivatives useful in treating acute ischemia-induced neurodegeneration
IL129276A (en) Anticonvulsant derivatives useful in treating neuropathic pain
PL329217A1 (en) Pain relieving method
GB9605828D0 (en) Treatment method
DE69732623D1 (en) Analogsignalmultiplexer in strombetriebsart
GB9425487D0 (en) Osteoarthritis treatment
IL127716A0 (en) Anticonvulsant derivatives useful in treating psoriasis
GB9506701D0 (en) Improvements in or relating to revolutions-counting apparatus
GB9604400D0 (en) Compounds useful in therapy
SI0964681T1 (en) Anticonvulsant derivatives useful in treating psoriasis
GB9620085D0 (en) Cosmetic treatment
SI0915697T1 (en) Anticonvulsant sulfamate derivatives useful in treating obesity
GB9515575D0 (en) Improvements in bulkheads
GB9519912D0 (en) Improvements in bioprocessors
GB9500585D0 (en) Improvements in baths
GB9614742D0 (en) Treatment method
GB9600610D0 (en) Treatment method

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees